Detailansicht

Univ.-Prof. Mag. Dr. Markus Mitterhauser
T: +43-1-4277-52620
Murgaš, M., Unterholzner, J., Stöhrmann, P., Philippe, C., Godbersen, G. M., Nics, L., Reed, M. B., Vraka, C., Vanicek, T., Wadsak, W., Kranz, G. S., Hahn, A., Mitterhauser, M., Hacker, M., Kasper, S., & Lanzenberger, R. (2023). Effects of bilateral sequential theta-burst stimulation on 5-HT1A receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial. Translational Psychiatry, 13(1), [33]. https://doi.org/10.1038/s41398-023-02319-3


Kiss, A., Wu, P., Schlederer, M., Pilz, P. M., Szabo, P. L., Li, J., Weber, L., Vraka, C., Pichler, V., Mitterhauser, M., Zhang, X., Zins, K., Abraham, D., Li, S., Podesser, B. K., Hacker, M., & Li, X. (2022). Sympathetic nerve innervation and metabolism in ischemic myocardium in response to remote ischemic perconditioning. Basic research in cardiology, 117(1), [42]. https://doi.org/10.1007/s00395-022-00946-3



Bencurova, K., Friske, J., Anderla, M., Mayrhofer, M., Wanek, T., Nics, L., Egger, G., Helbich, T. H., Hacker, M., Haug, A., Mitterhauser, M., & Balber, T. (2022). CAM-Xenograft Model Provides Preclinical Evidence for the Applicability of [68Ga]Ga-Pentixafor in CRC Imaging. Cancers, 14(22), [5549]. https://doi.org/10.3390/cancers14225549

Balber, T., Raitanen, J., Benčurová, K., Franssen, T., Schwarzl, P., Kalla, J., Culig, Z., Hacker, M., Egger, G., & Mitterhauser, M. (2022). In vitro investigation of a potential complementary expression of the imaging biomarkers AR and PSMA during prostate cancer progression. European Journal of Nuclear Medicine and Molecular Imaging, 49(Suppl.1), S329-S330.

Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2022). First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-D-aspartate Receptor with (R)-C-11-Me-NB1. Journal of Nuclear Medicine, 63(6), 936-941. https://doi.org/10.2967/jnumed.121.262427

Rasul, S., Beitzke, D., Wollenweber, T., Rausch, I., Lassen, M. L., Stelzmüller, M. E., Mitterhauser, M., Pichler, V., Beyer, T., Loewe, C., & Hacker, M. (2022). Assessment of left and right ventricular functional parameters using dynamic dual-tracer [13N]NH3 and [18F]FDG PET/MRI. Journal of Nuclear Cardiology, 29(3), 1003-1017. https://doi.org/10.1007/s12350-020-02391-y



Rischka, L., Murgaš, M., Pichler, V., Vraka, C., Rausch, I., Winkler, D., Nics, L., Rasul, S., Silberbauer, L. R., Reed, M. B., Godbersen, G. M., Unterholzner, J., Handschuh, P., Gryglewski, G., Mindt, T., Mitterhauser, M., Hahn, A., Ametamey, S. M., Wadsak, W., ... Hacker, M. (2022). Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1. EJNMMI Research, 12(1), [53]. https://doi.org/10.1186/s13550-022-00925-8


Rischka, L., Vraka, C., Pichler, V., Rasul, S., Nics, L., Gryglewski, G., Handschuh, P., Murgas, M., Godbersen, G. M., Silberbauer, L. R., Unterholzner, J., Wotawa, C., Haider, A., Ahmed, H., Schibli, R., Mindt, T., Mitterhauser, M., Wadsak, W., Hahn, A., ... Ametamey, S. M. (2021). First-in-human mapping of the GluN2B subunits of the N-methyl-D-aspartate receptor using (R)-[(11)Cc]Me-NB1 and PET. European Journal of Nuclear Medicine and Molecular Imaging, 48(SUPPL 1), 296.


Philippe, C., Klebermass, E-M., Balber, T., Kulterer, O. C., Zeilinger, M., Egger, G., Dumanic, M., Herz, C. T., Kiefer, F. W., Scheuba, C., Scherer, T., Fuernsinn, C., Vraka, C., Pallitsch, K., Spreitzer, H., Wadsak, W., Viernstein, H., Hacker, M., & Mitterhauser, M. (2021). Discovery of melanin-concentrating hormone receptor 1 in brown adipose tissue. Annals of the New York Academy of Sciences, 1494(1), 70-86. https://doi.org/10.1111/nyas.14563


Hana, C. A., Klebermass, E. M., Balber, T., Mitterhauser, M., Quint, R., Hirtl, Y., Klimpke, A., Somloi, S., Hutz, J., Sperr, E., Eder, P., Jašprová, J., Valášková, P., Vítek, L., Heiss, E., & Wagner, K. H. (2021). Inhibition of Lipid Accumulation in Skeletal Muscle and Liver Cells: A Protective Mechanism of Bilirubin Against Diabetes Mellitus Type 2. Frontiers in Pharmacology, 11, [636533]. https://doi.org/10.3389/fphar.2020.636533

Sauerzopf, U., Weidenauer, A., Dajic, I., Bauer, M., Bartova, L., Meyer, B., Nics, L., Philippe, C., Pfaff, S., Pichler, V., Mitterhauser, M., Wadsak, W., Hacker, M., Kasper, S., Lanzenberger, R., Pezawas, L., Praschak-Rieder, N., & Willeit, M. (2021). Disrupted relationship between blood glucose and brain dopamine D2/3 receptor binding in patients with first-episode schizophrenia. NeuroImage: Clinical, 32, [102813]. https://doi.org/10.1016/j.nicl.2021.102813


CAM-Xenograft Modell liefert präklinische Evidenz für Anwendung von [68Ga]Ga-Pentixafor in CRC-Bildgebung,

Katarina Benčurová (Vortragende*r), Joachim Friske (Autor*in), Maximilian Anderla (Autor*in), Manuela Mayrhofer (Autor*in), Thomas H Helbich (Autor*in), Marcus Hacker (Autor*in), Alexander R. Haug (Autor*in), Markus Mitterhauser (Autor*in) & Theresa Balber (Autor*in)

22 Sep. 2022

Aktivität: VorträgeVortragScience to Science


Vergleich der Strahlensensibilität zwischen 2D- und 3D-Zellkulturmodellen verschiedener menschlicher Krebszelllinien

Julia Raitanen (Vortragende*r), Bernadette Barta (Autor*in), Marcus Hacker (Autor*in), Dietmar Georg (Autor*in), Theresa Balber (Autor*in) & Markus Mitterhauser (Autor*in)

22 Sep. 2022

Aktivität: VorträgeVortragScience to Science


Comparison of radiation response between 2D and 3D cell culture models of different human cancer cell lines

Julia Raitanen (Vortragende*r), Bernadette Barta (Autor*in), Marcus Hacker (Autor*in), Dietmar Georg (Autor*in), Theresa Balber (Autor*in) & Markus Mitterhauser (Autor*in)

19 Sep. 2022

Aktivität: VorträgeVortragScience to Science


Of Mice and Men - Applied Diagnostics

Markus Mitterhauser (Invited speaker)

4 Apr. 2022

Aktivität: VorträgeVortragScience to Science


A bone model for the reduction of future animal experiments?

Markus Mitterhauser (Vortragende*r)

10 Jan. 2008

Aktivität: VorträgeVortragAndere


Ist [68Ga]EDTMP brauchbar für Knochenscans?

Markus Mitterhauser (Vortragende*r)

25 Jan. 2007

Aktivität: VorträgeVortragAndere


A new model for the pre vivo-evaluation of bone seekers?

Markus Mitterhauser (Autor*in)

10 Jan. 2004

Aktivität: VorträgeVortragAndere


Institut für Anorganische Chemie

Währinger Straße 42
1090 Wien

T: +43-1-4277-52620

markus.mitterhauser@univie.ac.at